RE: AVACTA - my view19 Apr 2023 11:11
We can remember it Myles, but I'd be surprised (and extremely delighted) to see it in black and white in the TU and the outline of the route to market. At this stage I'm sure it'll very much be a presentation of business as usual with some timelines that people might not initially like and the FUDters will jump on - but that's because they *could* receive accelerated approval from the FDA / MHRA. Once that becomes a fact, it not only starts to bring in revenues much sooner than ever imagined, it helps set expectations for the pipeline realising value for future prospects too.
It's about the science, the market is as thick as mince. A biotech is always going to be looking for funding and loss making until it makes a breakthrough. The pathfinder is providing that breakthrough - It Works (tm). Once it happens, be that via a licence, NASDAQ, continued progression via a death spiral, milestones then the value will out. I'd be surprised if Big Pharma allow this tech to disrupt their market when they've got the cash piles ready.